Compounds
The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, X, q and n are as defined in claim 1, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.
Glaxo Group Limited
A A A A A A A A A C C A A A A A C A
A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D C07D A61P A61P A61P A61P A61P C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Roberto Francesca Giuseppe Markus David
Profeta Bonetti Alvaro Bergauer Amantini